Bigul

SMS Lifesciences India Ltd - 540679 - Establishment Inspection Report (US FDA)

Company has received Establishment Inspection Report (EIR) from U.S. Food and Drug Administration (US FDA) for the inspection conducted in the month of April, 2022.
24-06-2022
Bigul

SMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for TV Praveen & Sudeepthi Gopineedi
23-06-2022
Bigul

SMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mrs. Sudeepthi Gopineedi
18-06-2022
Bigul

SMS Lifesciences India Ltd - 540679 - Violation Report (Insider Trading Code)

Report pursuant to Clause 13 of Schedule B & Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations 2015 read along with SEBI Circular no SEBI/HO/ISD/ISD/CIR/P /2020/135 dated July 23, 2020.
15-06-2022
Bigul

SMS Lifesciences India Ltd - 540679 - Related Party Transactions For The Half Year Ended March 31, 2022

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions for the half year ended March 31, 2022.
09-06-2022
Bigul

SMS Lifesciences India Ltd - 540679 - Corporate Information

Enclosed disclosure pursuant to BSE Circulars No. LIST/COMP/54/2019-20 dated 20/01/2020 and LIST/COMP/57/2019-20 dated 27/01/2020.
01-06-2022
Bigul

SMS Lifesciences India Ltd - 540679 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Enclosed is the Annual Secretarial Compliance Report F22.
30-05-2022
Bigul

SMS Lifesciences India Ltd - 540679 - Newspaper Publication (Financial Results)

Enclosed copies of newspaper advertisement.
30-05-2022
Bigul

SMS Lifesciences India Ltd - 540679 - Update On Subsidiary (Change In Board)

Mr. Venkata Praveen Talluri has been appointed as Managing Director and Mr. Madhu Rao Maganty as Nominee Director in Mahi Drugs Private Limited.
29-05-2022
Bigul

SMS Lifesciences India Ltd - 540679 - Reappointment Of Auditor(S)

Secretarial Auditor and Cost Auditor are reappointed for the year 2022-23.
29-05-2022
Next Page
Close

Let's Open Free Demat Account